DeepSTARR predicts enhancer activity from DNA sequence and enables the de novo design of synthetic enhancers

Bernardo P. de Almeida(Research Institute of Molecular Pathology), Alexander Stark(Research Institute of Molecular Pathology), Michaela Pagani(Research Institute of Molecular Pathology), Franziska Reiter(Research Institute of Molecular Pathology)
Nature Genetics
May 1, 2022
Cited by 296


Related Papers